Spectrofluorimetric Method for the Determination of Aluminum with Alizarin Red PS

 A simple and direct spectrofluorimetric method has been developed for the determination of aluminum using alizarin red PS (1,2,4-trihydroxy 9,10-anthraquinone-3-sulfonic acid). The method is based on the strong fluorescence (480/564 nm) of Al³⁺ and alizarin red. Experimental parameters such as pH, concentration of the ligand, ionic strength of the solution, reaction time and temperature were optimized in order to maximize the analytical signal. Interferences of several ions (anions and cations) were studied and evaluated. The linear range of the method extends from 3 to 100 μg L⁻¹. Limit of detection (3s_b) was 0.9 μg L⁻¹. The method was tested with a silicate certified reference material. Interferences were eliminated by a liquid extraction with cupferron. Author for correspondence. E-mail: aucelior@rdc.puc-rio.br Received September 10, 2002; accepted January 15, 2003 Published online May 5, 2003     

A validated spectrofluorometric method for the determination of celecoxib in capsules

A rapid, selective, sensitive and simple fluorescence method was developed for the direct determination of celecoxib in capsules. The capsules were emptied, pulverized and dissolved in either ethanol or acetonitrile, sonicated and filtered. Direct fluorescence emission was measured at 355±5 nm (exciting at 272 nm). The method was fully validated and the recoveries were excellent, even in presence of excipients.     

氧氟沙星荷移络合物的荧光特性和应用

研究了电子受体氯冉酸(CL)和2,3 二氰5,6 二氯1,4 对苯醌(DDQ)与电子给体氧氟沙星之间的荷移反应。实验发现,氧氟沙星与以上两种电子受体在氯仿中可生成稳定的n π络合物,其荧光强度较之氧氟沙星分别增强了22和54倍。据此建立了两种基于荷移反应简便可靠地测定氧氟沙星的荧光光谱新方法。CL法和DDQ法测定氧氟沙星的质量浓度分别为0 06～2.4μg/mL和0 16～2.0μg/mL时,荧光强度与质量浓度呈良好的线性关系。该方法已用于药物制剂中氧氟沙星的测定,其回收率分别为98.4%～100.9%和98.5%～100.4%。     

偏最小二乘-同步荧光法测定人尿中黄蝶呤

建立了人尿中黄蝶呤含量测定的同步荧光分析方法。在pH 7.8 KH2PO4-NaOH缓冲溶液中,于Δλ为70 nm的条件下对黄蝶呤及其它蝶呤类化合物进行同步荧光扫描,所得的重叠波谱数据用主成分回归法(PCR)、偏最小二乘法(PLS)、经典最小二乘法(CLS)和径向基人工神经网络(RBF-ANN)等多元校正法进行处理,结果表明偏最小二乘法(PLS)的分析结果最好,其标准偏差为4.29%。该方法简便、快速、准确,避免了较繁琐的样品前处理过程,应用于人尿中黄蝶呤分析,结果令人满意。     

Two different strategies for the fluorimetric determination of piroxicam in serum

Two different spectrofluorimetric methods for the determination of piroxicam (PX) in serum are presented and discussed. One of them is based on the use of three-way fluorescence data and multivariate calibration performed with parallel factor analysis (PARAFAC) and self-weighted alternating trilinear decomposition (SWATLD). This methodology exploits the so-called second-order advantage of the three-way data, allowing to obtain the concentration of the studied analyte in the presence of any number of uncalibrated (serum) components. The method was developed following two different procedures: internal standard addition and external calibration with standard solutions, which were compared and discussed. The second approach investigated is based on the combination of solid-phase extraction (SPE) and room temperature fluorimetry. Both methods here presented yield satisfactory results. The concentration range in which PX could be determined in serum was 1–10 μg ml⁻¹. The limits of quantification for the experimental solutions using the chemometric approach were 0.09 μg ml⁻¹ for the standard addition mode and 0.12 μg ml⁻¹ using external calibration (both for PARAFAC and SWATLD algorithms). In the solid-surface fluorimetric method, the calibration graph was linear up to 0.22 μg ml⁻¹ and the limit of quantification was 0.02 μg ml⁻¹.     

Novel spectrofluorimetric method for the determination of sulfite with rhodamine B hydrazide in a micellar medium

A novel spectrofluorimetric method for the determination of sulfite using rhodamine B hydrazide as fluorogenic reagent in the presence of polyoxyethylene sorbitan monooleate (Tween 80) surfactant micelles is described. The method is based on the mixture of sulfite with rhodamine B hydrazide, a colorless, non-fluorescent substance in Tween 80 surfactant micelles which gives rhodamine B-like fluorescence emission. The fluorescence intensity increase is linearly related to the concentration of sulfite in the range 5-800 ng ml⁻¹ with a detection limit of 1.4 ng ml⁻¹ (3σ). The optimal conditions for the detection of sulfite are evaluated and the possible detection mechanism is also discussed. The method has been successfully applied to the determination of total sulfite in wines and compares well with the standard iodimetric method.     

Spectrofluorimetric determination of human serum albumin using a doxycycline-europium probe

A new spectrofluorimetric method is proposed for determination of human serum albumin (HSA) with the limit of detection at ng levels. Using doxycycline (DC)-europium (Eu³⁺) as a fluorescent probe, in a buffer solution of pH 10.2, HSA can remarkably enhance the fluorescence intensity of the DC-Eu³⁺ complex at 612 nm and the enhanced fluorescence intensity of Eu³⁺ is proportional to the concentration of HSA. Optimum conditions for the determination of HSA are also investigated. The linear ranges for HSA are 0-9.2 and 9.2-34.5 μg ml⁻¹ with limits of detection of 64 and 115 ng ml⁻¹, respectively. This method is simple, practical and relatively free of interference from coexisting substances, as well as much more sensitive than most of the existing assays. The determination results for human serum and urine samples are identical to those by the AOAO method, with relative standard deviations of five determinations of 1.1-3.6%. By the Rosenthal graphic method, the binding number and association constant of human serum albumin with the probe are 1.8 and 3.71×10⁵ l mol⁻¹, respectively.     

Determination of melatonin in commercial preparations by micellar electrokinetic chromatography and spectrofluorimetry

Melatonin was determined in pharmaceutical preparations by means of two simple and reliable analytical methods based on micellar electrokinetic chromatography (MEKC) and spectrofluorimetry. The fluorescence emission values were measured at λ=350 nm when exciting at λ=275 nm. The MEKC analysis was achieved using a system consisting of 40 mM SDS in phosphate buffer (20 mM, pH 7.5). The extraction of melatonin from the tablets was achieved by means of a simple one-step dissolution with methanol/water. Both methods were applied for the determination of melatonin in commercial formulations and galenic preparations. The MEKC procedure allows the quantitative determination of melatonin in all pharmaceutical preparations tested. On the contrary, the spectrofluorimetric method is not suitable for tablets which also contain tryptophan; this interference can be eliminated by a suitable liquid-liquid extraction procedure. The results obtained with the two methods are in good agreement and satisfactory in terms of precision and accuracy.     

Experimental design methodologies to optimise the spectrofluorimetric determination of Losartan and Valsartan in human urine

A spectrofluorimetric method has been developed for the determination of two angiotensin II receptor antagonists (ARA II): Losartan and Valsartan. A fractional factorial design and a central composite design were used. The key factors considered in the optimization process were pH, temperature and emission slit width. Maximum fluorescent intensity was established as response for each experiment. The response surfaces confirmed the robustness of the method. A clean-up procedure was used for urine samples that consisted of a solid-phase extraction using C8 cartridges. The total analysis time was lower than 30 min. This method proved to be accurate (RE, 8%), precise (intra- and inter-day coefficients of variation were lower than 8% and sensitive enough (LOQ c.a. 0.5 μg ml⁻¹) to be applied to the determination of Losartan and Valsartan in urine samples.     

A novel application of immobilization on membranes for the separation and spectrofluorimetric quantification of amiloride and furosemide in pharmaceutical samples

A new, simple and highly sensitive method for spectrofluorimetric determination of amiloride (AMI) and furosemide (FUR) in pharmaceuticals is presented. The proposed method is based on the separation of AMI from FUR by solid-phase extraction using a nylon membrane, followed by spectrofluorimetric determination of both drugs, on the solid surface and the filtered aqueous solution, respectively. AMI shows low native fluorescence, but its separation-preconcentration by immobilization (solid-phase extraction) on nylon membrane surface provides a considerable enhancement in fluorescence intensity. The fluorescence determination is carried out at λ_ex = 237, λ_em = 415 nm for FUR; and λ_ex = 365, λ_em = 406 nm for AMI. The calibration graphs are linear in the range 3.20 × 10⁻⁴ to 0.8 μg mL⁻¹and 1.33 × 10⁻³ to 4.0 μg mL⁻¹, for AMI and FUR, respectively, with a detection limit of 9.62 × 10⁻⁵ and 4.01 × 10⁻⁴ μg mL⁻¹ (S/N = 3). The commonly found excipients in commercial pharmaceutical formulations do not interfere. The developed method is successfully applied to the determination of both drugs in pharmaceutical formulations.